Cargando…
The Contributions of Fiber Atrophy, Fiber Loss, In Situ Specific Force, and Voluntary Activation to Weakness in Sarcopenia
The contributions of fiber atrophy, fiber loss, in situ specific force, and voluntary activation to weakness in sarcopenia remain unclear. To investigate, 40 older (20 women; age 72 ± 4 years) and 31 younger adults (15 women, age 22 ± 3 years) completed measurements. The knee extensor maximal volunt...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132117/ https://www.ncbi.nlm.nih.gov/pubmed/29529132 http://dx.doi.org/10.1093/gerona/gly040 |
_version_ | 1783354260294991872 |
---|---|
author | McPhee, Jamie S Cameron, James Maden-Wilkinson, Thomas Piasecki, Mathew Yap, Moi Hoon Jones, David A Degens, Hans |
author_facet | McPhee, Jamie S Cameron, James Maden-Wilkinson, Thomas Piasecki, Mathew Yap, Moi Hoon Jones, David A Degens, Hans |
author_sort | McPhee, Jamie S |
collection | PubMed |
description | The contributions of fiber atrophy, fiber loss, in situ specific force, and voluntary activation to weakness in sarcopenia remain unclear. To investigate, 40 older (20 women; age 72 ± 4 years) and 31 younger adults (15 women, age 22 ± 3 years) completed measurements. The knee extensor maximal voluntary torque (MVC) was measured as well as voluntary activation, patella tendon moment arm length, muscle volume, and fascicle architecture to estimate in situ specific force. Fiber cross-sectional area (FCSA), fiber numbers, and connective tissue contents were also estimated from vastus lateralis biopsies. The MVC, quadriceps volume, and specific force were 39%, 28%, and 17% lower, respectively, in old compared with young, but voluntary activation was not different. The difference in muscle size was due in almost equal proportions to lower type II FCSA and fewer fibers. Five years later (n = 23) the MVC, muscle volume and voluntary activation in old decreased an additional 12%, 6%, and 4%, respectively, but there was no further change in specific force. In situ specific force declines relatively early in older age and reduced voluntary activation occurs later, but the overall weakness in sarcopenia is mainly related to loss of both type I and II fibers and type II fiber atrophy. |
format | Online Article Text |
id | pubmed-6132117 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-61321172018-09-13 The Contributions of Fiber Atrophy, Fiber Loss, In Situ Specific Force, and Voluntary Activation to Weakness in Sarcopenia McPhee, Jamie S Cameron, James Maden-Wilkinson, Thomas Piasecki, Mathew Yap, Moi Hoon Jones, David A Degens, Hans J Gerontol A Biol Sci Med Sci The Journal of Gerontology: Biological Sciences The contributions of fiber atrophy, fiber loss, in situ specific force, and voluntary activation to weakness in sarcopenia remain unclear. To investigate, 40 older (20 women; age 72 ± 4 years) and 31 younger adults (15 women, age 22 ± 3 years) completed measurements. The knee extensor maximal voluntary torque (MVC) was measured as well as voluntary activation, patella tendon moment arm length, muscle volume, and fascicle architecture to estimate in situ specific force. Fiber cross-sectional area (FCSA), fiber numbers, and connective tissue contents were also estimated from vastus lateralis biopsies. The MVC, quadriceps volume, and specific force were 39%, 28%, and 17% lower, respectively, in old compared with young, but voluntary activation was not different. The difference in muscle size was due in almost equal proportions to lower type II FCSA and fewer fibers. Five years later (n = 23) the MVC, muscle volume and voluntary activation in old decreased an additional 12%, 6%, and 4%, respectively, but there was no further change in specific force. In situ specific force declines relatively early in older age and reduced voluntary activation occurs later, but the overall weakness in sarcopenia is mainly related to loss of both type I and II fibers and type II fiber atrophy. Oxford University Press 2018-09 2018-02-26 /pmc/articles/PMC6132117/ /pubmed/29529132 http://dx.doi.org/10.1093/gerona/gly040 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of The Gerontological Society of America. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | The Journal of Gerontology: Biological Sciences McPhee, Jamie S Cameron, James Maden-Wilkinson, Thomas Piasecki, Mathew Yap, Moi Hoon Jones, David A Degens, Hans The Contributions of Fiber Atrophy, Fiber Loss, In Situ Specific Force, and Voluntary Activation to Weakness in Sarcopenia |
title | The Contributions of Fiber Atrophy, Fiber Loss, In Situ Specific Force, and Voluntary Activation to Weakness in Sarcopenia |
title_full | The Contributions of Fiber Atrophy, Fiber Loss, In Situ Specific Force, and Voluntary Activation to Weakness in Sarcopenia |
title_fullStr | The Contributions of Fiber Atrophy, Fiber Loss, In Situ Specific Force, and Voluntary Activation to Weakness in Sarcopenia |
title_full_unstemmed | The Contributions of Fiber Atrophy, Fiber Loss, In Situ Specific Force, and Voluntary Activation to Weakness in Sarcopenia |
title_short | The Contributions of Fiber Atrophy, Fiber Loss, In Situ Specific Force, and Voluntary Activation to Weakness in Sarcopenia |
title_sort | contributions of fiber atrophy, fiber loss, in situ specific force, and voluntary activation to weakness in sarcopenia |
topic | The Journal of Gerontology: Biological Sciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132117/ https://www.ncbi.nlm.nih.gov/pubmed/29529132 http://dx.doi.org/10.1093/gerona/gly040 |
work_keys_str_mv | AT mcpheejamies thecontributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia AT cameronjames thecontributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia AT madenwilkinsonthomas thecontributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia AT piaseckimathew thecontributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia AT yapmoihoon thecontributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia AT jonesdavida thecontributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia AT degenshans thecontributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia AT mcpheejamies contributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia AT cameronjames contributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia AT madenwilkinsonthomas contributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia AT piaseckimathew contributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia AT yapmoihoon contributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia AT jonesdavida contributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia AT degenshans contributionsoffiberatrophyfiberlossinsituspecificforceandvoluntaryactivationtoweaknessinsarcopenia |